Tim Pearson

Tim Pearson is a seasoned executive in the biotechnology sector, currently serving as a Member of the Board of Directors at Korro Bio, Inc. and as CEO of Carrick Therapeutics. Pearson has held the position of Chairman of the Board at GlycoMimetics since March 2014 and was a member of the Board of Directors at Ra Pharmaceuticals from May 2016 to January 2020. Additionally, Pearson served as EVP and Chief Financial Officer at TESARO from May 2014 to February 2019 and at Catalyst Health Solutions, Inc. from August 2011 to July 2012. Pearson’s extensive career in finance within the biotech industry includes a notable tenure as EVP and Chief Financial Officer at MedImmune from September 1998 to August 2011. Educational qualifications include a Bachelor of Science in Business Administration from the University of Delaware and a Master of Science in Finance from Loyola University Maryland.